Recent Developments in Clinical Plasma Proteomics—Applied to Cardiovascular Research

Nicolai Bjødstrup Palstrøm, Rune Matthiesen, Lars Melholt Rasmussen, Hans Christian Beck*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

25 Downloads (Pure)


The human plasma proteome mirrors the physiological state of the cardiovascular system, a fact that has been used to analyze plasma biomarkers in routine analysis for the diagnosis and monitoring of cardiovascular diseases for decades. These biomarkers address, however, only a very limited subset of cardiovascular diseases, such as acute myocardial infarct or acute deep vein thrombosis, and clinical plasma biomarkers for the diagnosis and stratification cardiovascular diseases that are growing in incidence, such as heart failure and abdominal aortic aneurysm, do not exist and are urgently needed. The discovery of novel biomarkers in plasma has been hindered by the complexity of the human plasma proteome that again transforms into an extreme analytical complexity when it comes to the discovery of novel plasma biomarkers. This complexity is, however, addressed by recent achievements in technologies for analyzing the human plasma proteome, thereby facilitating the possibility for novel biomarker discoveries. The aims of this article is to provide an overview of the recent achievements in technologies for proteomic analysis of the human plasma proteome and their applications in cardiovascular medicine.

Original languageEnglish
Article number162
Issue number1
Number of pages20
Publication statusPublished - Jan 2022


  • Affinity proteomics
  • Cardiovascular disease
  • Mass spectrometry-based proteomics
  • Plasma proteomics


Dive into the research topics of 'Recent Developments in Clinical Plasma Proteomics—Applied to Cardiovascular Research'. Together they form a unique fingerprint.

Cite this